---
title: "4151.JP (4151.JP) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/4151.JP/news.md"
symbol: "4151.JP"
name: "4151.JP"
parent: "https://longbridge.com/en/quote/4151.JP.md"
datetime: "2026-05-20T19:30:35.429Z"
locales:
  - [en](https://longbridge.com/en/quote/4151.JP/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/4151.JP/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/4151.JP/news.md)
---

# 4151.JP (4151.JP) — Related News

### [Is Kyowa Kirin (TSE:4151) Pricing Reflect Its Mixed Long Term Share Performance](https://longbridge.com/en/news/286669028.md)
*2026-05-17T10:07:04.000Z*
> Kyowa Kirin's stock has seen mixed performance, with a 1.9% increase over the past week but a 5.7% decline year-to-date.

### [Kyowa Kirin secures FDA approval for Crysvita dosing update](https://longbridge.com/en/news/286546805.md)
*2026-05-15T08:42:45.000Z*
> Kyowa Kirin has received FDA approval for an updated dosing regimen of Crysvita, a treatment for X-linked hypophosphatem

### [Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress  | KURA Stock News](https://longbridge.com/en/news/286111526.md)
*2026-05-12T05:40:42.000Z*
> Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress | KURA

### [Kyowa Kirin and Kura initiate Phase II trial of ziftomenib for AML](https://longbridge.com/en/news/284346517.md)
*2026-04-27T10:32:56.000Z*
> Kyowa Kirin and Kura Oncology have initiated a Phase II trial of ziftomenib for adult patients with relapsed or refracto

### [](https://longbridge.com/en/news/281310033.md)
*2026-04-01T06:04:53.000Z*
> Japan Kirin Group will increase the prices of some wine products

### [Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation](https://longbridge.com/en/news/279853505.md)
*2026-03-19T22:10:37.000Z*
> Amgen and Kyowa Kirin have halted all clinical trials of rocatinlimab due to newly identified safety risks, including ma

### [Assessing Kirin Holdings Company (TSE:2503) Valuation After New Gut Microbiota Health Collaboration](https://longbridge.com/en/news/278199859.md)
*2026-03-07T05:58:44.000Z*
> Kirin Holdings Company (TSE:2503) is gaining attention after its subsidiary Kyowa Kirin partnered with Cowellnex and Met